ENERGI-F705PD, a potential disease-modifying therapy for Parkinson’s disease, was found to be safe and well tolerated in a Phase 1 clinical trial involving healthy volunteers, according to developer Energenesis Biomedical. Unlike currently available treatments, ENERGI-F705PD aims to address the causes of Parkinson’s and not just its symptoms.
Lysoway Therapeutics has received a $2.93-million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The funding will advance a potential new therapy that targets the TRPML1 protein, a promising approach designed to modify the disease’s progression rather than just treating symptoms. “This funding underscores growing…
The Parkinson’s Foundation has awarded more than $1 million in community grants to fund dozens of local programs that support mental health, exercise, and education in Parkinson’s disease across 38 U.S. states, as part of its ongoing efforts to help patients live better lives. Ninety local programs…
I recently saw a social media post from a friend who’d lost her dad. It turns out that her dad and mine shared a birthday, but her dad was six years younger. The post left me puzzled. How was it that my friend was clutching a hole in her chest…
People with Parkinson’s disease who live in disadvantaged communities tend to have more severe motor symptoms and greater motor disability, according to a study that shows that social and environmental factors, many of which may be modifiable, can influence the severity of the disease. “If environmental exposures or other…
Using mathematical models, researchers at the University of California, San Francisco (UCSF) successfully predicted how to adjust deep brain stimulation (DBS) settings to improve gait for people with Parkinson’s disease, according to a study. With these techniques, researchers could improve DBS and other neuromodulatory therapies that influence nerve…
When combined with deep brain stimulation (DBS), a dynamic, cycling-based exercise program for people with Parkinson’s disease produces changes in brain activity indicative of potential neural rewiring, according to a study. The research was conducted at University Hospitals in Cleveland and the Veterans Affairs Northeast Ohio Healthcare System,…
Note: This column describes the author’s own experiences with various medications used to treat Parkinson’s disease. Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. You know how when professional wrestlers or politicians take the stage, they’ll often play…
Infection with a common and otherwise harmless virus called human pegivirus (HPgV) might play a hidden role in Parkinson’s disease, particularly for those with specific genetic risks, according to a new study. “For a virus that was thought to be harmless, these findings suggest it may have important effects,…
Neu Health is launching its smartphone-based system to measure tremors in people with Parkinson’s disease in the U.S. The Food and Drug Administration (FDA) has cleared the company’s digital tool to track Parkinson’s symptoms remotely, which uses only a smartphone to measure tremor severity, reducing reliance on wearables…
Get regular updates to your inbox.
